Identification and characterization of LRP8 (apoER2) in human blood platelets

Journal of Lipid Research

Volumn 40, Issue 10, 1999, Pages 1925-1930

  Riddell, David R ^a   Vinogradov, Dimitri V ^a   Stannard, Anita K ^a   Chadwick, Nicholas ^a   Owen, James S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Apolipoprotein E; Apolipoprotein E receptor 2; Intracellular signalling; LDL receptor family; Nitric oxide; Platelet aggregation

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E2 RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; SEQUENCE ANALYSIS; THROMBOCYTE; THROMBOCYTE MEMBRANE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; APOLIPOPROTEINS E; BINDING SITES; BLOOD PLATELETS; CELL LINE; CELL MEMBRANE; CONSERVED SEQUENCE; CYSTEINE; HUMANS; HYPERLIPIDEMIAS; KINETICS; LDL-RECEPTOR RELATED PROTEIN 1; LIPOPROTEINS, VLDL; MEGAKARYOCYTES; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032855538     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Weisgraber, K. H. 1994. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45: 249-302.
2. de Knijff, P., and L. M. Havekes. 1996. Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach. Curr. Opin. Lipidol. 7: 59-63.
3. Linton, M. F., and S. Fazio. 1999. Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies. Curr. Opin. Lipidol. 10: 97-105.
4. Riddell, D. R., A. Graham, and J. S. Owen. 1997. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease. J. Biol. Chem. 272: 89-95.
5. Desai, K., K. R. Bruckdorfer, R. A. Hutton, and J. S. Owen. 1989. Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation. J. Lipid Res. 30: 831-840.
6. Higashihara, M., M. Kinoshita, T. Teramoto, S. Kume, and K. Kurokawa. 1991. The role of apoE in inhibitory effects of apoE-rich HDL on platelet function. FEBS Lett. 282: 82-86.
7. Gliemann, J. 1998. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. Biol. Chem. 379: 951-964.
8. Innerarity, T. L., R. E. Pitas, and R. W. Mahley. 1986. Lipoprotein-receptor interactions. Methods Enzymol. 129: 542-565.
9. Kim, D. H., K. Magoori, T. R. Inoue, C. C. Mao, H. J. Kim, H. Suzuki, T. Fujita, Y. Endo, S. Saeki, and T. T. Yamamoto. 1997. Exon/ intron organization, chromosome localization, alternative splicing, and transcription units of the human apolipoprotein E receptor 2 gene. J. Biol. Chem. 272: 8498-8504.
10. Willnow, T. E. 1998. Receptor-associated protein (RAP): a specialized chaperone for endocytic receptors. Biol. Chem. 379: 1025-1031.
11. Mahley, R. W., and B. Angelin. 1984. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv. Intern. Med 29: 385-411.
12. Kowal, R. C., J. Herz, K. H. Weisgraber, R. W. Mahley, M. S. Brown, and J. L. Goldstein. 1990. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 10771-10779.
13. Takahashi, S., K. Oida, M. Ookubo, J. Suzuki, M. Kohno, T. Murase, T. Yamamoto, and T. Nakai. 1996. Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3. FEBS Lett. 386: 197-200.
14. Schneider, W. J., and S. G. Young. 1999. Genetics and molecular biology. Curr. Opin. Lipidol. 10: 85-87.
15. Vittet, D., M. N. Mathieu, J. M. Launay, and C. Chevillard. 1992. Platelet receptor expression on three human megakaryoblast-like cell lines. Exp. Hematol. 20: 1129-1134.
16. Kim, D. H., H. Iijima, K. Goto, J. Sakai, H. Ishii, H. J. Kim, H. Suzuki, H. Kondo, S. Saeki, and T. Yamamoto. 1996. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 271: 8373-8380.
17. Novak, S., T. Hiesberger, W. J. Schneider, and J. Nimpf. 1996. A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse. J. Biol. Chem. 271: 11732-11736.
18. Dyer, C. A., D. P. Cistola, G. C. Parry, and L. K. Curtiss. 1995. Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor. J. Lipid Res. 36: 80-88.
19. Sun, X. M., and A. K. Soutar. 1999. Expression in vitro of alternatively spliced variants of the messenger RNA for human apolipoprotein E receptor-2 identified in human tissues by ribonuclease protection assays. Eur. J. Biochem. 262: 230-239.
20. Trommsdorff, R., J. P. Borg, B. Margolis, and J. Herz. 1998. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273: 33556-33560.
21. Trommsdorff, R., M. Gotthardt, T. Hiesberger, J. Shelton, W. Stockinger, J. Nimpf, R. E. Hammer, J. A. Richardson, and J. Herz. 1999. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and apoE receptor 2. Cell. 97: 689-701.
22. Goretzki, L., and B. M. Mueller. 1998. Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein. Biochem. J. 336: 381-386.
23. Pawson, T. 1995. Protein modules and signalling networks. Nature. 373: 573-580.
24. Glass, D. B., and S. B. Smith. 1983. Phosphorylation by cyclic GMP-dependent protein kinase of a synthetic peptide corresponding to the autophosphorylation site in the enzyme. J. Biol. Chem. 258: 14797-14803.
25. Sase, K., and T. Michel. 1997. Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc. Med. 7: 28-37.